The urinary excretion of corticosteroid sulfates by cancer patients
β Scribed by D. P. Rose; W. E. Fahl; L. Liskowski
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 324 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Urinary excretions of free cortisol and corticosteroid sulfates were determined in 31 female controls, 77 breast cancer patients, 14 cases of colonic cancer, and 7 patients with bronchial carcinoma. Elevated corticosteroid sulfate excretion was present in38% of patients with locally recurrent breast cancer and 30% of those with distant metastases, but in only 13% of the βearlyβ breast cancer cases. A similar abnormality was seen in colonic cancer. Urinary free cortisol was usually normal. ACTH stimulation in a normal subject produced marked increases of both urinary free cortisol and corticosteroid sulfates. It is concluded that elevated corticosteroid sulfate excretion in cancer patients arises from an increased cortisol production rate combined with increased sulfurylation of the steroid. In bronchial carcinoma patients, changes similar to those occurring in the ACTHβtreated normal subject may have resulted from ectopic ACTH production in the tumor.
π SIMILAR VOLUMES
In a n attempt to define a biochemical test which would be helpful in the care of individuals with malignant melanoma, urinary excretion of DOPA, homovanillic acid, dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid of 16 patients with advanced disease was measured. Abnormal
In patients with hepatobiliary diseases, considerable amounts of sulfated and glucuronidated bile acids are excreted in urine. Information on the biliary excretion of these compounds is lacking. We used an intestinal perfusion method to determine the biliary excretion of sulfated and glucuronidated
Modified nucleosides, formed post-transcriptionally in RNA by a number of modification enzymes, are excreted in abnormal levels in the urine of patients with malignant tumors. To test their usefulness as tumor markers, and to compare them with the conventional tumor markers, a reversed-phase high-pe